News Archives

News Archives

Avivagen Announces Results From Its Annual and Special Meeting of Shareholders

Ottawa, ON / TNW-Accesswire / April 12, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announced at the Corporation’s annual and special meeting of shareholders (AGM) held yesterday …Read More

Avivagen Reports Positive Proof of Concept in Preventing C. Difficile Infection

First Potential Human Application for Avivagen’s Proprietary Technology Ottawa, ON / TNW-Accesswire / April 10, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces positive results from a proof-of-concept study …Read More

Avivagen Announces a Follow-On Purchase Order of OxC-Beta™ Livestock From UNAHCO, Inc.

Ottawa, ON / TNW-Accesswire / April 6, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces an additional purchase order of the same value and quantity from …Read More

Avivagen Inc. Announces Filing of Meeting Materials, Details of Proposed Share Consolidation, and Change of Auditors

Ottawa, ON / TNW-Accesswire / March 3, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) (Avivagen or the Corporation), a life sciences company commercializing products intended to replace the antibiotics added to livestock feeds, intends to accelerate market access and the commercial uptake of its OxC-beta™ Livestock product, an innovative product that has …Read More

Avivagen Announces Grant of Stock Options

Ottawa, ON / TNW-Accesswire / Feb 27 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company commercializing products intended to replace the antibiotics added to livestock feeds, is accelerating market access and the commercial uptake of its OxC-beta™ Livestock product, an innovative product that has the potential to eliminate the …Read More

Avivagen Inc. Announces Results for the Quarter Ending January 31, 2017

Ottawa, ON / TNW-Accesswire / Feb 22 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company commercializing products intended to replace the antibiotics added to livestock feeds, announces its results for the first quarter ending January 31, 2017. The Company intends to accelerate market access and the commercial uptake of …Read More